Skip to content

William Martens Lee, MD

NPI 1043262512ActiveIndividual· Internal Medicine, Hepatology· Dallas, TX

Internal Medicine, Hepatology (MD) in Dallas, Texas, licensed in TX, with an NPI issued in May 2006. Part D covered 15 prescriptions written in 2024, 93% of them generic. Glaxosmithkline, LLC. was the largest of 3 companies reporting payments in 2025, $10,532 in all, mostly consulting fees.

Overview

NPI1043262512
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 16, 2006
Last updated in NPPESApr 3, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Hepatology Primary207RI0008XH9452TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Gastroenterology (TX)

Part D prescriptions in 2024

Prescriptions (claims)15 · 37 30-day fills
Total drug cost$2,998
Generic share93% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$10,532 · 9 payments from 3 companies
  • 2024$24,386 · 13 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$7,2004
E.R. Squibb & Sons, L.L.C.$3,2251
Novo Nordisk Inc$106.794

What the 2025 payments were for

  • Consulting Fee$10,425 · 5 payments
  • Food and Beverage$106.79 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hepatology providers in Dallas

All Internal Medicine, Hepatology providers in Texas →